ABSTRACT
Introduction
For many years, it was believed that the spleen was not an important organ, and that its removal would cause no major repercussions. As a result, total splenectomy was performed indiscriminately, regardless the severity of the trauma or disease 1 . Nowadays, complications derived from splenectomy are well known and worrisome because of their seriousness. In order to reduce these complications, total splenectomy has been progressively replaced by procedures that preserve the splenic tissue 2 . The better knowledge of the spleen and its functions has influenced the use of less invasive procedures 3, 4 .
There are situations in which it is not possible to preserve the spleen and then splenectomy becomes inevitable. In these circumstances, the autogenous splenic implant is able to keep, at least in part, splenic functions with small risk of complications.
According to Holdsworth, Griffini and Tizzone 5 performed the first splenic implants in dogs. In 1896, Albrecht performed this surgery in humans in order to treat splenic traumas.
The spleen function of removing foreign substances, bacteria (mainly the capsulated ones) and senescent erythrocytes from the body was studied by scintigraphy and macrophages counting in the upper pole and in autogenous splenic implants in rats 6 . It should be considered that, especially in splenic trauma, keeping the upper spleen pole may be infeasible and that there must be an alternative treatment. Once concerned about this possibility, Paul et al. 7 performed a subtotal splenectomy preserving the lower spleen pole in dogs, which remained macroscopically feasible in 86.6% of the cases, even with the ligature of the main splenic vessels. 7 The lower polo viability was also observed in rats [8] [9] [10] [11] .
Studies on the phagocytic function of the remaining lower pole from subtotal splenectomy as well as studies comparing this technique with autogenous splenic implants were not found in the literature. This gap motivated the current study.
Methods
This study followed the Ethical Principles of Animal Prospective, experimental research, performed in 36 male Wistar rats, aged between 2 and 3 months with average weight of 364 ± 60 grams. The animals were divided into seven groups of five animals, with the exception of the second group which consisted of six animals, according to the postoperative follow-up time period, i.e.: one day (G1), seven days (G7 ) thirty days (G30), sixty days (G60) ninety days (90), one hundred and twenty days (120) and one hundred and fifty days (150).
The animals were placed in appropriate cages and were properly identified and kept in suitable conditions for the studied species. They received appropriate feed and water ad libitum. The phagocytic functions of the remaining lower pole and autogenous splenic implants were verified by sodium phytate splenic uptake and by counting macrophages, which were performed after the animals were euthanized. The colloidal carbon was obtained from India ink, which consists of soot mixed with gum arabic and fragrance. Such ink was placed in a Becker bottle, and subsequently, in a drying oven at 100ºC. The remaining pulp was diluted at the ratio of 50g/100ml water. The animals were anesthetized with ketamine and xylazine hydrochloride three hours before the removal of tissues for study purposes. A colloidal carbon solution was injected, by using a one milliliter syringe, at a dose of 1ml/ kg in the rat's right jugular vein for counting macrophages.
After two hours, a sodium phytate solution injection labeled with 110MBq (3mCi) of 99m technetium (99m Tc) was applied for splenic uptake. Three hours (3h) after the initial colloidal carbon injection, each animal was euthanized by means of intraperitoneal injection of pentobarbital (3% hipnol) at a dose of 120mg/kg of body weight. When no response was found to stimuli, 10% potassium chloride was injected in the 0.5 ml intracardiac dose. Then, re-laparotomy was performed in the same incision and the lower pole and autogenous splenic implants were removed for phagocytic function evaluation. 13 . In all tests, the 5% significance alpha level was used.
Results
Subtotal splenectomy -maintaining the lower spleen pole -and autogenous splenic implants were feasible in all animals. There was one death in G60 after colloidal carbon injection. In the second laparotomy, the lower pole and the autogenous splenic implants were not found in an animal from G30 and in another one from G90. Several adhesions were found around the implants and the lower pole, making it sometimes difficult to remove these splenic remnants. By analyzing each group of animals, it was observed that the weight of autogenous splenic implants was greater than that of the lower pole in G1, G7, G30, G60 and G120 (p<0.05). However, there was no difference in the G90 and G150 groups (p>0.05).
The radioisotopes uptake was higher in the autogenous splenic implants than it was in the lower spleen pole in G7 and G120 (p<0.05); however, there was no difference in the other groups (p>0.05) ( Table 1 ).
The number of macrophages was higher in the autogenous splenic implants than it was in the lower spleen pole in G1, G60, G90 and G120 (p<0.05). In the other groups, the difference was not significant (p>0.05) ( By histological evaluation, it was possible to see that animals from groups G7 and G30 showed almost the same characteristics. Figure 1 shows necrosis foci with severe fibrosis and vascular neoformation. In the G60, G90, G120 and G150 groups, the microscopic morphology of the autogenous splenic implant was considered as normal, since splenic tissue with splenic capsule (white arrow) and lymphoid follicles (pink arrow) are present ( Figure 2 ).
Discussion
In this study, an animal from G60 died shortly after the colloidal carbon injection. Its autopsy did not define the cause of death. It happened probably due to embolism once the animal showed respiratory failure followed by death right after the radioactive substance was administered. Lower spleen pole and autogenous splenic implants were not found in an animal from G30 and in another one from G90. A mass of about 4 cm, with fibrous tissue shell containing infectious-like material, was found in one of these animals, in the same location of the autogenous splenic implant and the lower pole. It is likely that these structures have undergone necrosis, followed by abscess. In another animal, the probable cause for the absence of structures was not found.
G7 had an extra animal because it was considered as the most controversial group regarding the phagocytic function recovery time in the autogenous splenic implants and lower pole.
However, the results found for this animal did not differ from the ones found for the other animals.
Abnormalities were not found in the control fragment removed from the spleen. The histological architecture was considered as normal in all of them.
It is known that the spleen tissue exerts its function in several parts of the body in which it is implanted. In this study, we chose to implant them into the greater omentum, which has abundant vascularization and which venous drainage goes towards the portal vein. The splenic blood flows directly to the liver, as well as it happens in normal conditions with the ectopic spleen venous drainage, which shows the best results according to the literature. Nevertheless, in the lack of omentum there is also an option for the mesentery or mesocolon, which drainage processes are also related to the portal system 14, 15 .
Another aspect of great importance for the autogenous splenic implant success is the amount of spleen tissue needed to maintain splenic function. Studies have shown the need for at least 25% of normal splenic tissue in order to obtain the proper spleen function 15, 16 . In the current study, the implants contained splenic mass exceeding 30% of rat's normal splenic mass.
In the first postoperative week of this study, there was no radioisotope uptake by the autogenous splenic implants (radioisotope uptake with a mean of 0.4 is considered insignificant).
However, on the seventh postoperative day, the autogenous splenic implant showed evidences of phagocytic function which is characterized by both radioisotope uptake and the presence of colloidal carbon within their macrophages. The radioisotope uptake increased gradually until the date of the last group (G150) in both structures. This fact shows that the phagocytic function requires a period of time to fully recover. It is worth remembering that, in the current study, the splenic tissue mass from the autogenous splenic implant was significantly higher than the lower spleen pole mass.
This may explain, in part, the best phagocytic function of these implants when compared with the lower pole, because the spleen function regeneration seems to be directly related to the implanted splenic mass 15 .
In the radioisotope uptake analysis performed in the separated groups, it was found that there was no difference between the autogenous splenic implants and the lower pole in G1, G30, G60, G90 and G150. In groups G7 and G120, however, the uptake by the autogenous splenic implant was higher, showing a significant difference. Importantly, the implants' weight was significantly higher than the lower pole one in these two groups.
In the phagocytic function analysis by counting macrophages, it was found that the counting of macrophages was higher in G1, G60, G90 and G120, in which there were also significant differences in the autogenous splenic implant weights when compared with the lower spleen pole weight. Perhaps, it can justify the abovementioned results. G150 showed difference neither in radioisotope uptake nor in the number of macrophages between the autogenous splenic implant and the lower spleen pole.
There was also no difference between the autogenous splenic implant and lower pole weights. The lower pole seems to grow over time, and thus improve its function 8 .
After the initial period of necrosis, the autonomous splenic implant is able to regenerate itself. The neovascularization originates from the arterial branches surrounding the implantation area. In the case of omental implant, it comes from gastro-omental arteries, with venous drainage towards the portal vein, similar to the spleen in situ, with centripetal orientation relative to the implant, starting a few days after this procedure 17, 18 .
It is emphasized that results from the current study found that animals from G1, G7 and G30 showed necrotic areas and that the autogenous splenic implants morphological aspect was quite normal in the animals from G60, G90, G120 and G150, when compared with the in situ histological study of a spleen. This fact reinforces the autogenous splenic implant regeneration concept, which is in agreement with the results found in another study 17 , in which the histopathological analysis showed architecture typical of a normal spleen. There was morphological regeneration in all animals subjected to autogenous splenic implant.
Technical aspects related to the autogenous splenic implant have been reported and most authors consider that this procedure is not associated with major complications 19, 21 .
The immunocompetence degree that the autogenous splenic implant can provide to the host in response to bacteria have been investigated 18, 21 . This procedure was performed in humans and the laboratory and scintigraphic tests found the recovery of some spleen functions. It has proved itself capable of removing colloidal and bacterial substances from rat's circulation 6, 22 .
The autogenous splenic implant has not been widely performed in the treatment of traumatic splenic injuries. This practice should be encouraged and further research should be carried out aiming to develop less invasive techniques for treating spleen diseases, because when part of this organ is preserved, splenic function is maintained and asplenia adversities are prevented.
Conclusion
Up to the 16th week, the phagocytic function was more pronounced in autogenous splenic implants when compared with the lower spleen pole, but it became similar after this period. 
